At execution time, the H‑Scheduler monitors spike traffic and dynamically migrates workloads to balance power consumption across the mesh. If a hotspot emerges (e.g., a burst of visual events), the scheduler can:
| Year | Planned Feature | |------|-----------------| | 2025 | Release of HMN‑384‑V2 with 48‑bit ADC option (up to 10 MS/s) and integrated on‑board AI inference accelerator (Xilinx Versal). | | 2026 | Introduction of a compact 2‑U variant (HMN‑384‑C) for edge deployments, with optional battery operation for field data loggers. | | 2027 | Full cloud‑native integration via a native Azure‑IoT Edge module, enabling real‑time streaming analytics without a local PC. | | 2028 | Open‑source firmware initiative to encourage community‑driven mezzanine development (e.g., custom DSP blocks). | HMN-384
We evaluated the antiproliferative activity of HMN-384 across a panel of breast cancer cell lines. HMN-384 exhibited potent cytotoxicity in TNBC lines (MDA-MB-231, BT-549) with GI50 values ranging from 12 to 28 nM, whereas luminal breast cancer lines (MCF-7, T47D) were significantly less sensitive. At execution time, the H‑Scheduler monitors spike traffic
Mechanistically, treatment with HMN-384 resulted in: whereas luminal breast cancer lines (MCF-7